146 related articles for article (PubMed ID: 11856774)
1. Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome.
Ray P; Acheson D; Chitrakar R; Cnaan A; Gibbs K; Hirschman GH; Christen E; Trachtman H
J Am Soc Nephrol; 2002 Mar; 13(3):699-707. PubMed ID: 11856774
[TBL] [Abstract][Full Text] [Related]
2. Non-enteropathic hemolytic uremic syndrome: causes and short-term course.
Constantinescu AR; Bitzan M; Weiss LS; Christen E; Kaplan BS; Cnaan A; Trachtman H
Am J Kidney Dis; 2004 Jun; 43(6):976-82. PubMed ID: 15168377
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome.
Ray PE; Liu XH; Xu L; Rakusan T
Pediatr Nephrol; 1999 Sep; 13(7):586-93. PubMed ID: 10460507
[TBL] [Abstract][Full Text] [Related]
4. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury.
Trachtman H; Christen E; Cnaan A; Patrick J; Mai V; Mishra J; Jain A; Bullington N; Devarajan P;
Pediatr Nephrol; 2006 Jul; 21(7):989-94. PubMed ID: 16773412
[TBL] [Abstract][Full Text] [Related]
5. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.
Thurman JM; Marians R; Emlen W; Wood S; Smith C; Akana H; Holers VM; Lesser M; Kline M; Hoffman C; Christen E; Trachtman H
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1920-4. PubMed ID: 19820137
[TBL] [Abstract][Full Text] [Related]
6. Determination of the age-related changes of serum basic fibroblast growth factor (bFGF) level in healthy Japanese subjects.
Okamoto Y; Tanaka M; Miyahara N; Tanabe M; Gotoh Y; Fujita N; Fukui T; Masuzawa T
Clin Lab; 2009; 55(3-4):114-9. PubMed ID: 19462933
[TBL] [Abstract][Full Text] [Related]
7. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
8. Urinary podocyte mRNA excretion in children with D+HUS: a potential marker of long-term outcome.
De Petris L; Patrick J; Christen E; Trachtman H
Ren Fail; 2006; 28(6):475-82. PubMed ID: 16928616
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
[TBL] [Abstract][Full Text] [Related]
10. Plasma cytokine levels in hemolytic uremic syndrome.
van de Kar NC; Sauerwein RW; Demacker PN; Grau GE; van Hinsbergh VW; Monnens LA
Nephron; 1995; 71(3):309-13. PubMed ID: 8569980
[TBL] [Abstract][Full Text] [Related]
11. Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
Karpman D; Andreasson A; Thysell H; Kaplan BS; Svanborg C
Pediatr Nephrol; 1995 Dec; 9(6):694-9. PubMed ID: 8747107
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.
Ninchoji T; Nozu K; Nakanishi K; Horinouchi T; Fujimura J; Yamamura T; Minamikawa S; Ishimori S; Nakanishi K; Yoshikawa N; Morioka I; Kaito H; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):889-894. PubMed ID: 28074307
[TBL] [Abstract][Full Text] [Related]
13. Timing and utility of ultrasound in diarrhea-associated hemolytic uremic syndrome: 7-year experience of a large tertiary care hospital.
Glatstein M; Miller E; Garcia-Bournissen F; Scolnik D
Clin Pediatr (Phila); 2010 May; 49(5):418-21. PubMed ID: 20075028
[TBL] [Abstract][Full Text] [Related]
14. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome.
Lipiec K; Adamczyk P; Świętochowska E; Ziora K; Szczepańska M
Adv Clin Exp Med; 2018 Jul; 27(7):955-962. PubMed ID: 29905409
[TBL] [Abstract][Full Text] [Related]
15. Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.
Shimizu M; Kuroda M; Sakashita N; Konishi M; Kaneda H; Igarashi N; Yamahana J; Taneichi H; Kanegane H; Ito M; Saito S; Ohta K; Taniguchi T; Furuichi K; Wada T; Nakagawa M; Yokoyama H; Yachie A
Cytokine; 2012 Dec; 60(3):694-700. PubMed ID: 22929411
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome.
Trachtman H; Christen E
Curr Opin Pediatr; 1999 Apr; 11(2):162-8. PubMed ID: 10202627
[TBL] [Abstract][Full Text] [Related]
17. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of a fibroblast growth factor binding protein in children with renal diseases.
Liu XH; Aigner A; Wellstein A; Ray PE
Kidney Int; 2001 May; 59(5):1717-28. PubMed ID: 11318942
[TBL] [Abstract][Full Text] [Related]
19. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
20. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
